Seema Khan, MD, Northwestern University, Chicago, IL, Joseph Michael Guenther, MD, St. Elizabeth HealthCare, Edgewood, KY, Amy Degnim, MD, Mayo Clinic, Rochester, MN, Melissa Pilewskie, MD, Memorial Sloan Kettering Cancer Center, New York, NY, E. Shelley Hwang, MD, Duke University, Durham, NC, Stephen Grobmyer, MD, Cleveland Clinic, Cleveland, OH
The purpose of this study was to compare the effects of a tamoxifen pill to tamoxifen (4-OHT) gel on breast cells in women with ER+ DCIS. This study investigated what effects each treatment has on the DCIS and what side effects each treatment may cause.
The initial Call to Action for this study was on 2/16/2018 and the researchers closed enrollment on 6/15/2021. The Love Research Army provided them with 5 participants who were interested in enrolling in the study.